SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-017806
Filing Date
2020-07-17
Accepted
2020-07-17 16:30:13
Documents
2
Period of Report
2020-07-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea124295-8k_intecpharma.htm 8-K 58155
2 INTEC PHARMA LTD. COMPENSATION POLICY FOR EXECUTIVE OFFICERS AND DIRECTORS ea124295ex10-1_intecpharma.htm EX-10.1 92616
  Complete submission text file 0001213900-20-017806.txt   152072
Mailing Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512
Business Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512 97225864657
Intec Pharma Ltd. (Filer) CIK: 0001638381 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37521 | Film No.: 201034050
SIC: 2834 Pharmaceutical Preparations